OBJECTIVES: The aim of this study was to evaluate the safety and effectiveness of a fast-track surgery (FTS) protocol on patients undergoing minimally invasive oesophagectomy.
INTRODUCTION
The concept of fast-track surgery (FTS) has been recently introduced by Henrik Kehlet [1] , with the intent to relieve postoperative stress, reduce the morbidity associated with complications, accelerate recovery and, eventually, reduce postoperative costs [2] . FTS requires a multidisciplinary team during the entire perioperative period to reach an optimal outcome [3] . To date, FTS has been successfully applied to some type of thoracic surgery; exclusively to minimally invasive lobectomy. However, few studies have been able to prove whether FTS could also be safely applied to oesophageal surgery, such as oesophageal tumour resection [4, 5] , and there have not been any reports with regard to the application of FTS on patients with oesophageal cancer receiving minimally invasive oesophagectomy (MIO). The aim of the present study was to evaluate the safety and effectiveness of FTS on patients receiving MIO such as patients' preoperative/ intraoperative characteristics, postoperative stay, postoperative morbidity and mortality, and so on.
MATERIALS AND METHODS

Patients
Eighty patients underwent MIO for oesophageal cancer performed by the same surgical team, in the Department of Thoracic Surgery of the First Affiliated Hospital of Anhui Medical University between January 2012 and April 2013. All 80 patients were operated on consecutively and no patient was excluded during the study period. All the patients underwent preoperative examinations, including gastroscopy, barium meal of the upper gastrointestinal tract, abdominal ultrasonography, chest computed tomography, pulmonary function tests and haematological examinations. Given that the endoscopic ultrasonography had just been imported to our institution and the positron emission tomography scanning examination is expensive, most of the patients did not undergo these two important examinations.
The relevant preoperative/intraoperative characteristics of patients are shown in Table 1 . The design of our study comprised two cohorts. Group 1 (n = 40) comprised patients who were operated on from January 2013 to April 2013 who underwent fast-track rehabilitation. Group 2, the control cohort, comprised patients who underwent conventional care from January 2012 to June 2012 (n = 40). A well-defined multimodal rehabilitation programme was followed in all patients, as described in Table 2 .
Selection criteria for minimally invasive oesophagectomy
Patients who met the following requirements were eligible for MIO [6] : (i) age 25-85 years old, male or female; (ii) diagnosis confirmed by endoscopic biopsy; (iii) no distant metastasis diagnosed by preoperative abdominal ultrasonography or computed tomography; (iv) no history of autoimmune or severe cardiopulmonary diseases; (v) no preoperative radiotherapy or chemotherapy; (vi) clinical tumor-node-metastasis classification ≤T3N2M0; (vii) tumours that could not be resected by endoscopic mucosal resection and endoscopic sub-mucosal dissection; (viii) American Society of Anesthesiologists score ≤I-II; (ix) serum albumin >30 g/l; and (x) acceptance by the patients and their families.
All patients were informed both orally and in writing about the MIO techniques. Patients in Group 1 were informed about the pre-and postoperative multimodal rehabilitation programme and the expected discharge 5-7 days after operation.
Surgical procedures
All the patients were intubated with a double-lumen tube for single left lung ventilation. The mobilization of the oesophagus and mediastinal lymphadenectomy were performed using a thoracoscopic approach in the left lateral decubitus position using the methods mentioned [7] ; the thoracic cavity was rinsed with warm water ( 40°C) and two 20-French chest tubes were inserted for postoperative drainage. The patients were then repositioned in a supine position; the mobilization of stomach without pyloroplasty and lymph node dissection around the stomach were performed with four ports and a small upper abdominal mid-line incision ( 4 cm). A 3-cm neck incision of the anterior border of the sternocleidomastoid was made and the cervical oesophagus was mobilized and exposed. The cervical oesophagus was divided, and the distal oesophageal stump was sutured and bound with long silk suture. The oesophagogastric specimen was then pulled up out of the tiny upper abdominal mid-line incision. A 3-to 4-cm-diameter gastric tube was then constructed starting at the distal lesser curve, preserving the right gastric vessels using five to six firings of a linear stapler (Ethicon Endo-Surgery, Cincinnati, OH, USA), and the gastric seromuscular layer was intermittently sutured to embed the gastric stump. The gastric tube was attached to the sutures that were pulled out from the neck. An additional suture was placed on the anterior proximal gastric tube to facilitate correct orientation as the tube was brought up to the neck [7] . A gastrotomy was created at the tip of the gastric conduit. A 21-mm or 25-mm circular end to end anastomotic stapler was placed into the gastric remnant for construction of the oesophagogastric anastomosis. The gastrotomy was closed with a linear stapler. Finally, a duodenal feeding tube (Nutricia Advanced Medical Nutrition, Netherlands) was connected to the jejunum. 
Fast-track surgery programme
A computerized clinical care pathway of FTS was designed to help guide the planned care of these patients, which included the following: (i) a semiliquid meal was administered up to 6 h before surgery with a carbohydrate drink (commonly 200 ml 10% glucose solution) up to 3 h before surgery; (ii) no nasogastric tube decompression; (iii) no abdominal drainage tube; (iv) no draining sinus in the neck; (v) the chest tube was removed if drainage <300 ml/day and the tube and catheter were removed as early as possible; (vi) prevention of hypothermia therapy; (vii) restrictive intravenous fluids intraoperatively and postoperatively (1.8-2.2 l/day); (viii) early postoperative enteral nutrition (EN), 6 h after surgery, starting at 20 ml/h; (ix) optimization of analgesia (according to Anaesthesia Department suggestions); (x) all patients were sent directly to the floor unless they had a history of coronary artery disease; (xi) an attempt at bedside rehabilitation on POD 2; and (xii) oral feeding was initiated at 48 h after surgery, following a step-wise programme from warm clear water to fluid meals, and finally to semifluid meals and normal food. The amount and concentration of initial oral intake were adapted to the state of gastrointestinal function and individual tolerance [8] .
In the FTS group, wound inspection and suture removal were recommended to take place in the outpatient clinic 8-9 days post surgery. Following histopathological examination results, the patients were referred for further oncology treatment.
Conventional programme
The conventional care pathway that is different from the fast-track pathway is as follows: (i) no meal for 12 h and no drink for 8 h before surgery; (ii) routine use of nasogastric tube decompression, abdominal drainage tube and draining sinus in the neck; (iii) chest tube was removed if drainage <50 ml/day; (iv) no prevention of hypothermia therapy; (v) conventional fluid infusion regimen (2.5-2.8 l/day); (vi) postoperative EN, 2 days after surgery; (vii) all patients were sent directly to the intensive care unit (ICU); (viii) an attempt at bedside rehabilitation on POD 4; (ix) if the cervical incision showed no symptoms of leak, temperature was normal, blood routine was normal, the patient was advanced to a small amount of clear liquids 6 days after surgery, following a step-wise programme from warm clear water to fluid meals, and finally to semifluid meals and normal food.
Measurement indices
The following clinical parameters were recorded: age, sex, pathological tumour stage, preoperative albumin level, time of first flatus (index of peristalsis recovery), postoperative hospital stay, mortality (defined as any death occurring during the hospital stay or within 30 days postoperatively), rehospitalization rates and the POD of: initial diet (warm water) and full liquid diet introduction, drain removal, vesicular catheter removal and postoperative complications.
Discharge criteria
We defined the postoperative discharge day for the patients in the trial when they met all of the discharge criteria: (i) total liquid diet (eating multiple small meals) without intravenous nutritional support; (ii) no nausea or vomiting, and good flatus and/or defecation; (iii) well controlled with oral analgesics; (iv) no drainage tubes or catheters; (v) able to carry out normal daily activities, and care for themselves; (vi) acceptance by the patients; (vii) enteral feeding via the duodenal feeding tube was continued at home and compressed over a 12-h period from 7 pm to 7 am; and (viii) normal body temperature.
Follow-up
All patients were seen at follow-up in the outpatient surgery clinic 8-10 and 30 days after the operation. If necessary, they could contact us at any time. From the information received, we could decide whether to intervene and plan further treatment.
Statistical analysis
Statistical analysis was performed using the SPSS version 18.0 software (SPSS, Chicago, IL, USA). A P-value <0.05 was considered to be statistically significant.
RESULTS
There were 58 men and 22 women. The median age was 64 (58.25-69) years. Tumours were located in the distal oesophagus in seven cases (9%), in midoesophagus in 69 cases (86%) and in the upper oesophagus in four cases (5%). The relevant characteristics of patients are shown in Table 1 . Both groups comprised patients with the same distribution of physical characteristics: age, gender, pathology, tumour location, pathologic Tumor-NodeMetastasis stages, preoperative albumin level and anaesthetic risk.
The location of the patients in the early postoperative time period changed drastically after the introduction of the FTS. We found that 100% of patients in the conventional group were in ICU. In the FTS group, we started to avoid ICU for all 40 patients; all patients were sent to the floor from the postanesthesia care unit with heart rhythm and pulse oximetry continuously monitored. We noted no difference in the outcomes between these patients. In addition, a nasogastric tube was prescribed to all patients in the conventional group, but none of the patients in the FTS group needed a nasogastric tube during their postoperative time. The average quantity of postoperative fluid transfusion in the FTS group was 2.1 (2.06-2.2) vs 2.8 (2.7-2.9) l in the conventional group (P <0.001). The chest tube was removed at POD 3 (2-4) in the FTS group versus at POD 8 (6-9.75) in the conventional care group (P <0.001). The incidence of complications was 29% in patients of the FTS programme group and 40% in those of the conventional care group. No significant differences were observed in the incidence of complications, 30-day readmission rate or reoperation rate between the two groups within 30 days after MIO of oesophageal cancer. No patient died in either group. The median postoperative hospital stay time was 7 (6-9) and 12 (10-16.5) days, respectively, for the patients in the FTS programme group and the conventional care group (P <0.001). Patients in the FTS group also showed significantly accelerated recovery of gastrointestinal function compared with the conventional group in terms of flatus time [3 (3-4) vs 6 (6-7) days, P <0.001] and initiation of diet [2 (2-3) vs 9 (8-10) days, P <0.001]. Two patients in the conventional group and three patients in the FTS group were readmitted after discharge. The reasons for readmission were late chylothorax (1), gastric stump fistula (1), cervical anastomotic leakage (1) and pulmonary infection (2). In our study, nasogastric tubes gave 100% of the patients a sore throat and caused 13% to vomit in the conventional group, whereas in the FTS group, they caused pharyngalgia in 43% (P <0.001) and vomiting in 3% (P >0.05). The types of morbidity and mortality are listed in Table 3 , and the other outcomes are listed in Table 4 . In the FTS group, some postoperative morbidity was found during follow-up. Three patients had minor anastomotic leak at the neck following hospital discharge. Cervical fistula drainage and EN support were the main treatments that can be implemented in the outpatient clinic or the local hospital. Only one patient was readmitted to our institution to receive treatment for 10 days, and another two patients were cured in the outpatient clinic and the local hospital for 8 and 14 days, respectively . The duodenal feeding tube, which was retained for at least 14 days, was the most important preventive measure against anastomotic leak. Two patients experienced chylothorax in the FTS group; one of these had minor chylothorax at POD 3 and drainage <500 ml/ day; she recovered after chest drainage and parenteral nutrition (PN) nutritional support for 14 days. The other patient had chylothorax at POD 29 following hospital discharge; he was readmitted to the local hospital for treatment, and recovered after chest drainage and PN nutritional support for 20 days.
DISCUSSION
Anhui Province, with a population of 69 000 000, is an area with high occurrence of oesophageal cancer in China. The incidence of oesophageal cancer in our province is approximately 21.37 per 100 000, and the mortality was approximately 19.10 per 100 000 in 2012. Our institution, the first affiliated hospital of Anhui Medical University, is the biggest and most advanced university tertiary care centre in Anhui Province. We began performing MIOs in 2009 and, since then, we have performed 200 such operations per year and accumulated a great deal of experience.
Traditional views about perioperative care of oesophageal surgery patients have been challenged by recent studies. Recently, FTS has been widely used for general surgery [9] , heart surgery [10] , lobectomy [11] and so on. The aim of FTS is to decrease the incidence of complications, reduce postoperative stimulative response and hospitalization. The first data regarding the care of oesophageal surgery patients following FTS were reported by Robert James Cerfolio in 2004 [12] . It has been shown that FTS in oesophagectomy is safe and efficient, and it can accelerate rehabilitation and shorten postoperative hospital stay [13] , as was demonstrated in our present study. In our study, postoperative hospital stay and the days until intestinal activity were significantly shortened in the FTS group without an increase in morbidity or mortality. Postoperative hospital stay was decreased from the traditional 12 to 7 days through the use of FTS, with similar complication rates.
In our study, there were no differences between the two groups with regard to vomiting, but patients in the conventional group felt pharyngalgia considerably more than the FTS group. In the FTS group of the present study, no patient underwent routine in-dwelling nasogastric tube placement, which did not show a statistically significant difference in the incidence of pulmonary complications, emesis, gastroplegia or anastomotic leakage from Pulmonary complications include atelectasis, pulmonary infection, acute respiratory distress syndrome and respiratory insufficiency. b When we found a red sore swollen neck incision, we always opened the neck and placed a drain; when we found the change in drain output or mucus from the neck incision, the anastomotic leak was confirmed. 
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the conventional care group with routine in-dwelling tube retention. Some studies demonstrated that forgoing gastrointestinal decompression might be a momentous step for faster functional restoration of the gastrointestinal tract and decrease of the postoperative hospital stay. Studies show that the nasogastric tube gave 88% of the patients discomfort and 70% patients even more severe feelings of discomfort, and normal gastrointestinal functions were markedly delayed [14, 15] . A recent study showed that the nasogastric tube had not reduced the complications of gastrointestinal surgery [16] . Meanwhile, the nasogastric tube caused disturbance of water, electrolyte and acid base, and promoted digestive fluid reflux, which led to pulmonary complications [17] . Daryaei et al. [18] demonstrated that the incidence of anastomosis leak was significantly higher in patients who used the nasogastric tube after oesophagectomy. Many surgeons and anaesthesiologists have always been wary of allowing an oesophageal cancer patient to ingest liquids 3 h before induction of anaesthesia, which could lead to aspiration pneumonia. The practice of overnight fasting before elective surgery maintains its place in tradition. However, prolonged starvation, by its catabolic action, can increase the detrimental effects of surgery and aggravate insulin resistance. However, administration of 500 ml peptisorb (SP) (NUTRICIA, Holland) and 200 ml 10% glucose can reduce insulin resistance and enhance the tolerance of patients to the operation without increasing anaesthesia risk [19] . National and European Anaesthesia Societies now recommend the intake of clear fluids until 2 h before the induction of anaesthesia as well as a 6-h fast for solid food [20] ; so we followed these guidelines and instructed patients to drink fluid meals until 6 h before surgery and a carbohydrate drink (commonly 200 ml 10% glucose solution) until 3 h before surgery. Based on our analysis provided, there is no difference between the two groups in pulmonary complications.
Anastomotic leakage has been the major puzzle for early oral food consumption after operations. Owing to surgeons' fear of early oral feeding, it was delayed in patients. In our present study, there were no statistically significant differences between the two groups in terms of atrial arrhythmia, pneumonia, anastomotic leak or mortality rates. In our study, three cases had leakage in the neck in the FTS group, but no evidence indicated leakage related to early diet and cancellation of the nasogastric tube. Lewis et al. [21] conducted a meta-analysis that concluded that early enteral nutrition can reduce the risk of pulmonary complications, anastomotic leakage and mortality. Early postoperative oral diet and nutritional intake can not only guarantee the structure and function of intestinal mucosal cells, alleviate intestinal barrier dysfunction and decrease the incidence of bacterial trans-location, but also increase portal circulation, activate the intestinal digestive secretory system, reduce postoperative infection complications and accelerate organ recovery [22] . In the present study, most patients who underwent FTS well tolerated an early oral diet. Therefore, we suggest that an early oral diet in patients with MIO is safe and feasible.
Enteral nutrition is more suitable for physiological demands with fewer complications and lower price [23] . Previous research has shown that the small intestine might return to normal function 6 h after abdominal surgery, so that liquid can be reabsorbed in the small intestine at an early stage postoperatively [16] . In the FTS group, patients were fed 500 ml SP at full concentration by a duodenal feeding tube, 6 h after surgery, starting at 20 ml/h. Patients did not present with abdominal pain, abdominal bulge or vomiting; however, the recovery of gastrointestinal function in the FTS group was faster than in the conventional group in terms of flatus time.
The evidence shows that strict intravenous infusion administration intraoperatively and postoperatively can reduce stimulative response, decrease cardiopulmonary complications and shorten the duration of hospital stay [24] . In our study, the average quantity of fluid transfusion in the FTS group was significantly less than that in the conventional group. Although there were no statistically significant differences in the rates of morbidity or mortality, one could encourage patients to ambulate earlier and reduce costs. If the enteral nutrition postoperatively and the early oral diet postoperatively can be carried out earlier, the intravenous infusion postoperatively can be reduced to as little as possible.
The abdominal cavity drainage tube in MIO is for drainage and monitoring active bleeding, but it can lead to complications, such as abdominal infection and intestinal obstruction. Once it has been confirmed that there is no active haemorrhage in the peritoneal cavity, the physician can forgo an in-dwelling peritoneal cavity tube. In this study, the peritoneal cavity was drained in every patient in the conventional care group, but no patient underwent routine in-dwelling peritoneal cavity tube placement in the FTS group. This study did not show statistically significant differences in the rates of anastomotic disruption, extra-abdominal complications, reoperation or mortality between the two groups. Jesus et al. [25] also indicated that there were no statistically significant differences in the rates of morbidity or mortality.
Chest tube drainage causes pain and limits patient mobility, occasionally reducing cough efficiency. In this study, the chest tube was removed as early as possible in the FTS group. There were no significant differences between the two groups in terms of morbidity and mortality. A recent study showed that it is safe to remove the thoracic drainage tube when the drainage volume is between 250 and 450 ml. Early ambulation of patients after surgery is a universally accepted part of a fast-track programme. It shows that early ambulation can prevent venous thromboembolism, and promote the recovery of intestinal function and lung function. Therefore, the earlier the drainage tubes are removed, the earlier patients get out of bed, which could also accelerate the recovery of enteral function.
As with FTS principles, the concept of evidenced-based anaesthetic care and multimodal analgesia is a reasonable approach to care. Reasonable analgesia can increase the patients' confidence with treatment and accelerate the recovery of gastrointestinal function. Meanwhile, the patient can ambulate, eat and be discharged as early as possible.
In summary, our research showed that patients who received MIO can tolerate FTS, leading to an early recovery without increasing morbidity, mortality or amount of readmissions. The major goal of FTS is to control postoperative stress reaction and improve patients' recovery. The present consequences arise from a retrospective controlled study and not a randomized, controlled trial. Also, there were some limitations of the study design; for example, the sequential nature of the study arms (control group older than the study group) is an inherent source of potential selection bias. These results should be interpreted with caution. The use of patient randomization and the associated prospective data collection are considered to be more accurate. Following this trend in the methodology should be the next step in studies on the use of FTS. Nevertheless, a larger series with longer follow-up evaluation is necessary for further validation of the conclusions reached in this study.
